BSECompany Update6d ago · 30 Jul 2026, 12:58 pm

Earnings Conference call Invite to discuss Un-audited Financial Results of the Company for the Quarter ended 30 June 2026.

Sai Life Sciences Ltd · 544306

✦ AI SummaryResults

Sai Life Sciences Ltd is hosting an earnings conference call on August 7, 2026, to discuss its un-audited financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

8eb125e9-1ce7-4764-8802-9e422a8181e1.pdf

pdf

Download →
View document text
Date: 30 July 2026 To To National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Bandra Kurla Phiroze Jeejeebhoy Towers, Dalal Street Complex, Bandra (E), Mumbai – 400 051 Mumbai – 400001 NSE Scrip Symbol: SaiLife BSE Scrip Code: 544306 Sub: Intimation of schedule of Earnings conference call. Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company is hosting the Earnings Conference call on Friday, 07 August 2026, at 04:00 PM (IST) for discussing Un Audited Financial Results of the Company for the Quarter ended 30 June 2026. Complete details of the earnings conference call are attached herewith for your reference. We request you to take note of the same and oblige. Thank you. For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No.: A13721 Encl: As above Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Sai Life Sciences Q1FY27 Results Conference Call At 4.00 PM IST on August 7, 2026 (Friday) We are pleased to invite you to Sai Life Sciences Q1FY27 results conference call with the senior management. The conference call will be held on Friday, August 7, 2026, at 4:00 PM (IST). The call will be initiated with a brief management discussion on the earnings performance followed by an interactive Question & Answer session The details of the earnings call are: Date: August 7, 2026 | Time Slot (IST): 4:00 PM – 5:00 PM Dial-in Number: +91 22 6280 1107, +91 22 7115 8008 Other Dial in Numbers: International Toll Free: USA: 18667462133 | UK: 08081011573 | Singapore: 8001012045 | Hong Kong: 800964448 Pre-Registration Facility for the call and dial in directly without waiting for the operator: Click Here Or Copy this URL in your browser: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1777589&linkSecurityString=f0c5443f3 Management Representation from Sai Life Sciences Limited Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer Mr. Siva Chittor, Director and Chief Financial Officer About Sai Life Sciences Limited Sai Life Sciences is one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO) that partners with innovator pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new medicines. Headquartered in Hyderabad, India, with a strong global presence, the company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. Sai Life Sciences is committed to delivering high-quality, cost-effective, and scalable solutions while upholding the highest standards of safety, compliance, and integrity. With a focus on innovation and operational excellence, the company continues to strengthen its capabilities to support emerging therapeutic modalities and meet the evolving needs of the life sciences industry. For more information, please visit www.sailife.com For further information please contact: Investorrelation@sailife.com